Financhill
Sell
7

IQV Quote, Financials, Valuation and Earnings

Last price:
$194.01
Seasonality move :
-0.35%
Day range:
$193.83 - $198.90
52-week range:
$187.62 - $261.73
Dividend yield:
0%
P/E ratio:
26.20x
P/S ratio:
2.34x
P/B ratio:
5.70x
Volume:
1.7M
Avg. volume:
1.5M
1-year change:
-17.64%
Market cap:
$34.6B
Revenue:
$15.4B
EPS (TTM):
$7.50

Analysts' Opinion

  • Consensus Rating
    IQVIA Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $247.60, IQVIA Holdings has an estimated upside of 26% from its current price of $196.51.
  • Price Target Downside
    According to analysts, the lowest downside price target is $205.00 representing -4.32% downside risk from its current price of $196.51.

Fair Value

  • According to the consensus of 19 analysts, IQVIA Holdings has 26% upside to fair value with a price target of $247.60 per share.

IQV vs. S&P 500

  • Over the past 5 trading days, IQVIA Holdings has underperformed the S&P 500 by -2.65% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • IQVIA Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • IQVIA Holdings has grown year-over-year revenues for 18 quarters straight. In the most recent quarter IQVIA Holdings reported revenues of $4B.

Earnings Growth

  • IQVIA Holdings earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter IQVIA Holdings reported earnings per share of $2.42.
Enterprise value:
46.7B
EV / Invested capital:
2.33x
Price / LTM sales:
2.34x
EV / EBIT:
19.99x
EV / Revenue:
3.03x
PEG ratio (5yr expected):
9.10x
EV / Free cash flow:
22.11x
Price / Operating cash flow:
17.05x
Enterprise value / EBITDA:
13.54x
Gross Profit (TTM):
$5.4B
Return On Assets:
5.13%
Net Income Margin (TTM):
8.91%
Return On Equity:
21.32%
Return On Invested Capital:
6.85%
Operating Margin:
15.72%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $14.4B $15B $15.4B $3.9B $4B
Gross Profit $5B $5.2B $5.4B $1.4B $1.4B
Operating Income $1.8B $2.1B $2.3B $518M $622M
EBITDA $2.9B $3.3B $3.5B $870M $1B
Diluted EPS $5.71 $7.29 $7.50 $2.54 $2.42
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $5.1B $4.8B $5B $5.6B $5.8B
Total Assets $24.6B $24.7B $25.3B $26.7B $26.9B
Current Liabilities $4.6B $5.2B $5.6B $6.5B $7B
Total Liabilities $18.3B $18.6B $19.6B $20.6B $20.8B
Total Equity $6.3B $6B $5.8B $6.1B $6.1B
Total Debt $12.5B $12.1B $12.7B $13.7B $14B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $2.3B $2.1B $2.7B $747M $885M
Cash From Investing -$2B -$1.6B -$1.4B -$212M -$310M
Cash From Financing -$329M -$382M -$878M -$420M -$375M
Free Cash Flow $1.6B $1.5B $2.1B $568M $721M
IQV
Sector
Market Cap
$34.6B
$44.2M
Price % of 52-Week High
75.08%
48.19%
Dividend Yield
0%
0%
Shareholder Yield
3.7%
-0.68%
1-Year Price Total Return
-17.64%
-35.43%
Beta (5-Year)
1.478
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $199.12
200-day SMA
Sell
Level $219.56
Bollinger Bands (100)
Sell
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $201.75
Relative Strength Index (RSI14)
Sell
Level 41.13
ADX Line
Neutral
Level 0
Williams %R
Buy
Level -84.1935
50-day SMA
Sell
Level $200.30
MACD (12, 26)
Sell
Level -1.44
25-day Aroon Oscillator
Sell
Level -28
On Balance Volume
Neutral
Level --

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.1217)
Sell
CA Score (Annual)
Level (-1.0981)
Buy
Beneish M-Score (Annual)
Level (-2.7641)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.7593)
Buy
Piotroski F Score (Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Stock Forecast FAQ

In the current month, IQV has received 14 Buy ratings 5 Hold ratings, and 0 Sell ratings. The IQV average analyst price target in the past 3 months is $247.60.

  • Where Will IQVIA Holdings Stock Be In 1 Year?

    According to analysts, the consensus estimate is that IQVIA Holdings share price will rise to $247.60 per share over the next 12 months.

  • What Do Analysts Say About IQVIA Holdings?

    Analysts are divided on their view about IQVIA Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IQVIA Holdings is a Sell and believe this share price will drop from its current level to $205.00.

  • What Is IQVIA Holdings's Price Target?

    The price target for IQVIA Holdings over the next 1-year time period is forecast to be $247.60 according to 19 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is IQV A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for IQVIA Holdings is a Buy. 14 of 19 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of IQV?

    You can purchase shares of IQVIA Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IQVIA Holdings shares.

  • What Is The IQVIA Holdings Share Price Today?

    IQVIA Holdings was last trading at $194.01 per share. This represents the most recent stock quote for IQVIA Holdings. Yesterday, IQVIA Holdings closed at $196.51 per share.

  • How To Buy IQVIA Holdings Stock Online?

    In order to purchase IQVIA Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Is CVX a Buy, Sell or Hold?
Is CVX a Buy, Sell or Hold?

Energy giant Chevron Corporation (NYSE:CVX) has long been a pure-play…

What Will NVIDIA Stock Be Worth in 2030?
What Will NVIDIA Stock Be Worth in 2030?

NVIDIA (NASDAQ:NVDA) has been by far one of the best…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
17
CE alert for Feb 21

Celanese [CE] is down 4.21% over the past day.

Sell
22
GLBE alert for Feb 20

Global E Online [GLBE] is down 8.41% over the past day.

Buy
72
HIMS alert for Feb 20

Hims & Hers Health [HIMS] is down 3.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock